Gilead Sciences (NASDAQ:GILD) is scheduled to announce Q4 earnings results on Tuesday, February 4th, after market close.
The consensus EPS Estimate is $1.67 (+16.0% Y/Y) and the consensus Revenue Estimate is $5.74B (-1.0% Y/Y).
Over the last 2 years, gild has beaten EPS estimates 75% of the time and has beaten revenue estimates 63% of the time.
Over the last 3 months, EPS estimates have seen 4 upward revisions and 4 downward. Revenue estimates have seen 6 upward revisions and 3 downward.
https://seekingalpha.com/news/3537438-gilead-sciences-q4-2019-earnings-preview
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.